17 annual accounts with figures on one time axis, 48 filings since 1977
peak of €65.9m in 2023
€65.6m▼ 0.5%
lowest -€511,564 in 2023
€449,079▲ €960,643
peak of €4.3m in 2024
€4.3m▲ 16.6%
€12.2m▼ 53.2%
peak of 172.5 FTE in 2024
172.5 FTE▲ 39.2%
Board11 names since 2010
4 directorsName hiddenVisible after signing in and 3 others
Documentsfilings and deeds
29-08-202529 days late
2024financial year
Profit of €449,079, after a lossStaff from 123.9 FTE to 172.5 FTEMerger: Apotheek Antverpia takes over VITAFARMA, Hidden nameVisible after signing in and FARMA…26-08Merger proposal: APOTHEEK ANTVERPIA takes over VITAFARMA, B.V…10-06Company renamed from Apoteek Antverpia to Apotheek Antverpia01-02Equity from €3.7m to €4.3m
26-08-2024merger with B.V.B.A. Name hiddenVisible after signing in
Apotheek Antverpia went through 3 restructurings since 2024. On 26-08-2024, Apotheek Antverpia took over B.V.B.A. Hidden nameVisible after signing in by merger.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 736 companies had the same profile as Apotheek Antverpia has now. Each dot stands for 2 companies, two years later.
97.3%
were still trading
1.5%
stopped another way
1.0%
went bankrupt
Medium-sized
20 years or older
solvency 10 to 30%
a profit under 5% of the balance sheet
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 736 companies, not a prediction for Apotheek Antverpia. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Hidden nameVisible after signing in° appointed as statutory auditorName after signing inVisible after signing in acts as permanent representative · General meeting of 01-10-2025 · Gazette deed
Environmental permit granted
Change of use, Convert, more or fewer homes · decided by Kontich
Merger: Apotheek Antverpia takes over VITAFARMA, Name hiddenVisible after signing in and FARMA DE BOND
General meeting of 03-07-2024 · Gazette deed
Merger proposal: APOTHEEK ANTVERPIA takes over VITAFARMA, B.V.B.A. Hidden nameVisible after signing in and FARMA DE BONDName after signing inVisible after signing in, Name hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in act as permanent representatives · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as Apotheek Antverpia: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €12m and €32m, founded between 1901 and 1994.
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Antverpia?
Apotheek Antverpia is a public limited company (NV).
When was Apotheek Antverpia founded?
Apotheek Antverpia was founded on 01-01-1968.
Is Apotheek Antverpia still active?
Yes, Apotheek Antverpia is an active enterprise in the KBO register.
How many employees does Apotheek Antverpia have?
Apotheek Antverpia had an average of 172.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does Apotheek Antverpia fall under?
In its 2024 annual accounts, Apotheek Antverpia states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Apotheek Antverpia?
The turnover of Apotheek Antverpia was €65.6m in financial year 2024, according to the filed annual accounts.
Is Apotheek Antverpia profitable?
In financial year 2024, Apotheek Antverpia made a profit of €449,079.
Where can I find the annual accounts of Apotheek Antverpia?
Apotheek Antverpia filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
When are the next annual accounts of Apotheek Antverpia due?
Apotheek Antverpia had to file the annual accounts for financial year 2025 by 31-07-2026. On 19-11-2026 they are not filed yet, 111 days past the deadline.Timeline